{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:46:25Z","timestamp":1791773185617,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001464","name":"National Cancer Institute - Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.dld.2021.07.039","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T22:52:14Z","timestamp":1628808734000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"54","author":[{"given":"Jin Hean","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Hui","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin Kee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yew Chong","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Gottardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dld.2021.07.039_bib0001","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2021.07.039_bib0002","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2021.07.039_bib0003","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1016\/S0168-8278(14)60672-3","article-title":"Gastrointestinal ischemic in patients with acute and chronic portal vein thrombosis","volume":"60","author":"Harki","year":"2014","journal-title":"J. Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2021.07.039_bib0004","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep4.1513","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and advanced liver disease: an exploratory meta-analysis","volume":"4","author":"Violi","year":"2020","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.dld.2021.07.039_bib0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis","volume":"31","author":"Tsochatzis","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"31","key":"10.1016\/j.dld.2021.07.039_bib0006","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.3748\/wjg.v25.i31.4437","article-title":"Portal vein thrombosis in cirrhosis: why a well-known complication is still matter of debate","volume":"25","author":"Faccia","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.dld.2021.07.039_bib0007","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transplant"},{"issue":"11","key":"10.1016\/j.dld.2021.07.039_bib0008","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.cgh.2020.02.037","article-title":"Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation","volume":"18","author":"Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.dld.2021.07.039_bib0009","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/MEG.0b013e328357d5d4","article-title":"Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis","volume":"24","author":"Amitrano","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2021.07.039_bib0010","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis","volume":"156","author":"Intagliata","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2021.07.039_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.14740\/gr806w","article-title":"Efficacy and safety of direct-acting oral anticoagulants use in acute portal vein thrombosis unrelated to cirrhosis","volume":"10","author":"Nery","year":"2017","journal-title":"Gastroenterology Res"},{"issue":"12","key":"10.1016\/j.dld.2021.07.039_bib0012","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/tri.13353","article-title":"Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis","volume":"31","author":"Zanetto","year":"2018","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.dld.2021.07.039_bib0013","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2021.07.039_bib0014","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/1751-2980.12970","article-title":"Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)","volume":"22","year":"2021","journal-title":"J Dig Dis"},{"issue":"2","key":"10.1016\/j.dld.2021.07.039_bib0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2021.07.039_bib0016","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.dld.2021.07.039_bib0017","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e31826e8e53","article-title":"Management of Nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review","volume":"94","author":"Rodr\u00edguez-Castro","year":"2012","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.dld.2021.07.039_bib0018","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/MOH.0000000000000164","article-title":"Hemostasis abnormalities in cirrhosis","volume":"22","author":"Tripodi","year":"2015","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.dld.2021.07.039_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhepr.2019.02.006","article-title":"Anticoagulation in the cirrhotic patient","volume":"1","author":"Turco","year":"2019","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.dld.2021.07.039_bib0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ajg.2016.498","article-title":"Changing concepts of cirrhotic coagulopathy","volume":"112","author":"Tripodi","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.dld.2021.07.039_bib0021","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/hep.26372","article-title":"An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome","volume":"58","author":"Hugenholtz","year":"2013","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.dld.2021.07.039_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018917","article-title":"Direct oral anticoagulants in patients with inherited thrombophilia and venous thromboembolism: a prospective cohort study","volume":"9","author":"Campello","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.dld.2021.07.039_bib0023","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2019.10.026","article-title":"Practical use of direct oral anti coagulants (DOACs) in the older persons with atrial fibrillation","volume":"71","author":"Bo","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.dld.2021.07.039_bib0024","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11239-018-1622-5","article-title":"Direct oral anticoagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis","volume":"45","author":"Brunetti","year":"2018","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"10.1016\/j.dld.2021.07.039_bib0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"New Engl J Med"},{"issue":"10","key":"10.1016\/j.dld.2021.07.039_bib0026","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.dld.2021.07.039_bib0027","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.dld.2021.07.039_bib0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoka","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2021.07.039_bib0029","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vph.2018.05.002","article-title":"Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis","volume":"113","author":"Hanafy","year":"2019","journal-title":"Vascul Pharmacol"},{"issue":"2","key":"10.1016\/j.dld.2021.07.039_bib0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.thromres.2008.08.009","article-title":"Definition of major bleeding used by US anticoagulation clinics","volume":"124","author":"Seto","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.dld.2021.07.039_bib0031","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.dld.2021.07.039_bib0032","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of non-randomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.dld.2021.07.039_bib0033","series-title":"Cochrane handbook for systematic reviews of interventions version 6.2","article-title":"Chapter 8: assessing risk of bias in a randomized trial","author":"Higgins","year":"2021"},{"key":"10.1016\/j.dld.2021.07.039_bib0034","series-title":"Cochrane handbook for systematic reviews of interventionsversion 6.2","article-title":"Chapter 10: analysing data and undertaking meta-analyses","year":"2021"},{"issue":"6","key":"10.1016\/j.dld.2021.07.039_bib0035","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.dld.2021.07.039_bib0036","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.12844","article-title":"The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis","volume":"98","author":"Hum","year":"2017","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.dld.2021.07.039_bib0037","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/MEG.0000000000001958","article-title":"Evaluation of the efficacy and safety of direct oral anticoagulants in the treatment of portal vein thrombosis","volume":"33","author":"Ilcewicz","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.07.039_bib0038","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.14309\/01.ajg.0000706388.88885.06","article-title":"S1085\u2003Direct oral anticoagulants and warfarin in patients with cirrhosis and portal vein thrombosis: a comparison of outcomes","volume":"115","author":"Joseph","year":"2020","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"2","key":"10.1016\/j.dld.2021.07.039_bib0039","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11239-019-02035-0","article-title":"Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes","volume":"50","author":"Davis","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.dld.2021.07.039_bib0040","first-page":"1159A","article-title":"efficacy and safety of edoxaban for treatment of portal vein thrombosis in patients with liver cirrhosis","volume":"68","author":"Yuko","year":"2018","journal-title":"Hepatology"},{"issue":"13-14","key":"10.1016\/j.dld.2021.07.039_bib0041","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00508-018-1351-y","article-title":"Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function","volume":"130","author":"Scheiner","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.dld.2021.07.039_bib0042","first-page":"75","article-title":"The efficacy and safety of anticoagulant treatment for portal vein thrombosis","volume":"28","author":"Irina","year":"2019","journal-title":"J Gastrointest Liv Dis"},{"issue":"7","key":"10.1016\/j.dld.2021.07.039_bib0043","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0040-1722192","article-title":"Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"121","author":"Valeriani","year":"2021","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.dld.2021.07.039_bib0044","doi-asserted-by":"crossref","first-page":"e13397","DOI":"10.1111\/eci.13397","article-title":"Car. Direct oral anticoagulants and advanced liver disease: a systematic review and meta-analysis","volume":"51","author":"Menichelli","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2021.07.039_bib0045","article-title":"Comparison of the efficacy and safety of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation and concomitant liver cirrhosis: a systematic review and meta-analysis","author":"Lee","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.dld.2021.07.039_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8859602","article-title":"Safety and efficacy of anticoagulation in patients with cirrhosis: a meta-analysis","volume":"2021","author":"Chen","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.dld.2021.07.039_bib0047","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/qjmed\/hcz127","article-title":"Safety of direct oral anticoagulants in patients with cirrhosis: a systematic review and meta-analysis","volume":"112","author":"Lapumnuaypol","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.dld.2021.07.039_bib0048","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-021-02424-4","article-title":"Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis","author":"Nisly","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.dld.2021.07.039_bib0049","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2018.08.011","article-title":"Direct oral anticoagulants in patients with liver cirrhosis: a systematic review","volume":"170","author":"Hoolwerf","year":"2018","journal-title":"Thromb Res"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821004084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821004084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:17:47Z","timestamp":1761625067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821004084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1590865821004084"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.07.039","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}